EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 183 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,515,000 | +27.9% | 167,949 | +22.8% | 0.01% | +20.0% |
| Q3 2016 | $4,311,000 | +13.3% | 136,722 | +1.1% | 0.01% | 0.0% |
| Q2 2016 | $3,804,000 | -13.9% | 135,260 | +11.2% | 0.01% | -16.7% |
| Q1 2016 | $4,420,000 | -6.7% | 121,585 | +2.6% | 0.01% | 0.0% |
| Q4 2015 | $4,739,000 | +41.8% | 118,447 | +0.9% | 0.01% | +20.0% |
| Q3 2015 | $3,343,000 | -14.9% | 117,333 | -1.6% | 0.01% | 0.0% |
| Q2 2015 | $3,927,000 | +27.5% | 119,181 | +11.3% | 0.01% | +25.0% |
| Q1 2015 | $3,080,000 | +6.9% | 107,110 | +1.2% | 0.00% | 0.0% |
| Q4 2014 | $2,882,000 | +26.1% | 105,849 | -1.3% | 0.00% | +33.3% |
| Q3 2014 | $2,286,000 | -3.9% | 107,267 | +1.2% | 0.00% | 0.0% |
| Q2 2014 | $2,380,000 | -11.8% | 105,956 | -0.8% | 0.00% | -25.0% |
| Q1 2014 | $2,699,000 | +11.3% | 106,801 | +1.2% | 0.00% | 0.0% |
| Q4 2013 | $2,425,000 | +18.8% | 105,502 | -1.6% | 0.00% | +33.3% |
| Q3 2013 | $2,042,000 | +37.7% | 107,182 | +4.2% | 0.00% | 0.0% |
| Q2 2013 | $1,483,000 | – | 102,874 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
| Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
| AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
| RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
| EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
| SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
| Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
| DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |